Evidence map›Paper›PMID 29077871›Full record

ReviewPain medicine (Malden, Mass.)2018

From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain.

Theodore J Price, Michael S Gold

Abstract readReview
In one paragraph

Review in Pain medicine (Malden, Mass.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Objective evidence for chronic back pain relief by Medical Yoga therapy.Frontiers in pain research (Lausanne, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. MNK-eIF4E signalling is a highly conserved mechanism for sensory neuron axonal plasticity: evidence fromPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
  17. Article
  18. Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Theodore J PriceSchool of Behavioral and Brain Sciences, The University of Texas at Dallas, Dallas, Texas.
Michael S GoldDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Funding

Translation Control of Pain PlasticityR01NS065926 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI PRICE, THEODORE J. · 2010 to 2023
$5.7M
Protease Activated Receptor Type 2 Targeting for Migraine PainR01NS098826 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI GREGORY O DUSSOR, Theodore J. Price · 2017 to 2026
$3.4M
Peripheral GABAA Receptor SignalingR01DK107966 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOLD, MICHAEL S · 2016 to 2020
$1.9M
Mechanisms of MigraineR01NS083347 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOLD, MICHAEL S · 2014 to 2018
$1.8M
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAINR01GM102575 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI DUSSOR, GREGORY O, PRICE, THEODORE J. · 2013 to 2016
$1.1M
NIDDK NIH HHS R01 DK107966NIGMS NIH HHS R01 GM102575NINDS NIH HHS R01 NS065926NINDS NIH HHS R01 NS083347NINDS NIH HHS R01 NS098826
6 · The paper itself

Abstract

Objective: Persistent pain causes untold misery worldwide and is a leading cause of disability. Despite its astonishing prevalence, pain is undertreated, at least in part because existing therapeutics are ineffective or cause intolerable side effects. In this review, we cover new findings about the neurobiology of pain and argue that all but the most transient forms of pain needed to avoid tissue damage should be approached as a disease where a cure can be the goal of all treatment plans, even if attaining this goal is not yet always possible. Design: We reviewed the literature to highlight recent advances in the area of the neurobiology of pain. Results: We discuss barriers that are currently hindering the achievement of this goal, as well as the development of new therapeutic strategies. We also discuss innovations in the field that are creating new opportunities to treat and even reverse persistent pain, some of which are in late-phase clinical trials. Conclusion: We conclude that the confluence of new basic science discoveries and development of new technologies are creating a path toward pain therapeutics that should offer significant hope of a cure for patients and practitioners alike. Classification of Evidence. Our review points to new areas of inquiry for the pain field to advance the goal of developing new therapeutics to treat chronic pain.

Indexed as

Central Nervous System SensitizationChronic PainHumans

Identifiers

PMID29077871
PMCPMC6084577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.